M. Scriba

2.0k total citations · 1 hit paper
29 papers, 1.3k citations indexed

About

M. Scriba is a scholar working on Epidemiology, Immunology and Genetics. According to data from OpenAlex, M. Scriba has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 8 papers in Immunology and 7 papers in Genetics. Recurrent topics in M. Scriba's work include Herpesvirus Infections and Treatments (13 papers), Cytomegalovirus and herpesvirus research (8 papers) and Virus-based gene therapy research (7 papers). M. Scriba is often cited by papers focused on Herpesvirus Infections and Treatments (13 papers), Cytomegalovirus and herpesvirus research (8 papers) and Virus-based gene therapy research (7 papers). M. Scriba collaborates with scholars based in Austria, Germany and United States. M. Scriba's co-authors include Werner Henle, Gertrude Henle, Gary R. Pearson, Barbara Zając, Franz Tatzber, Rudolf Weil, Friedrich Dorner, Martine Wettendorff, Hans‐Joachim Schmoll and Claude R. Joyner and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

M. Scriba

28 papers receiving 1.1k citations

Hit Papers

Differential Reactivity of Human Serums with Early Antige... 1970 2026 1988 2007 1970 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Scriba Austria 15 664 552 359 317 170 29 1.3k
J Menezes Canada 23 854 1.3× 1.0k 1.9× 427 1.2× 702 2.2× 355 2.1× 42 1.9k
V. Vonka Czechia 20 859 1.3× 360 0.7× 321 0.9× 403 1.3× 95 0.6× 120 1.4k
K. L. Powell United Kingdom 27 1.3k 1.9× 288 0.5× 302 0.8× 332 1.0× 38 0.2× 40 1.8k
J E Callahan United States 11 367 0.6× 185 0.3× 485 1.4× 1.3k 4.2× 66 0.4× 14 1.9k
José Menézes Canada 25 590 0.9× 668 1.2× 323 0.9× 1.1k 3.5× 239 1.4× 76 2.0k
Suzanne E. Connaughton United States 8 246 0.4× 325 0.6× 122 0.3× 1.4k 4.3× 54 0.3× 8 1.7k
Martine Y. K. Armstrong United States 17 565 0.9× 175 0.3× 349 1.0× 430 1.4× 21 0.1× 27 1.2k
Diënne G. Elferink Netherlands 15 486 0.7× 111 0.2× 492 1.4× 888 2.8× 42 0.2× 25 1.4k
Nina Wedderburn United Kingdom 18 239 0.4× 276 0.5× 127 0.4× 365 1.2× 100 0.6× 55 931
Guy Warnier Belgium 20 242 0.4× 527 1.0× 126 0.4× 1.6k 4.9× 104 0.6× 30 2.1k

Countries citing papers authored by M. Scriba

Since Specialization
Citations

This map shows the geographic impact of M. Scriba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Scriba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Scriba more than expected).

Fields of papers citing papers by M. Scriba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Scriba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Scriba. The network helps show where M. Scriba may publish in the future.

Co-authorship network of co-authors of M. Scriba

This figure shows the co-authorship network connecting the top 25 collaborators of M. Scriba. A scholar is included among the top collaborators of M. Scriba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Scriba. M. Scriba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scriba, M., et al.. (1993). The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies. Infection and Immunity. 61(10). 4523–4526. 40 indexed citations
2.
Aulitzky, Walter E., Thomas F. Schulz, Herbert Tilg, et al.. (1991). Human Monoclonal Antibodies Neutralizing Cytomegalovirus (CMV) for Prophylaxis of CMV Disease: Report of a Phase I Trial in Bone Marrow Transplant Recipients. The Journal of Infectious Diseases. 163(6). 1344–1347. 40 indexed citations
3.
Ganzinger, U., et al.. (1991). Pharmacokinetics of an Anti‐Cytomegalovirus Hyperimmunoglobulin after Single Intravenous Administration to Healthy Volunteers. Vox Sanguinis. 60(4). 203–206. 1 indexed citations
4.
Peichl, P., M. Scriba, G Haberhauer, & H Bröll. (1988). Selective Binding of Rheumatoid Factors to Antigen Structures of Cytomegalovirus (CMV). Scandinavian Journal of Rheumatology. 17(sup75). 117–122. 1 indexed citations
5.
Tilg, Herbert, R Margreiter, M. Scriba, et al.. (1987). Clinical presentation of CMV infection in solid organ transplant recipients and its impact on graft rejection and neopterin excretion. Clinical Transplantation. 1(1). 37–43. 13 indexed citations
6.
Richardson, Vernon J., et al.. (1987). Reinfection of guinea pigs with herpes simplex virus type 2: failure to establish a second latent ganglionic infection. Canadian Journal of Microbiology. 33(8). 679–683. 1 indexed citations
7.
Herlyn, Dorothee, Martine Wettendorff, Hans‐Joachim Schmoll, et al.. (1987). Anti-idiotype immunization of cancer patients: modulation of the immune response.. Proceedings of the National Academy of Sciences. 84(22). 8055–8059. 138 indexed citations
8.
Scriba, M.. (1982). Animal studies on the efficacy of vaccination against recurrent herpes. Medical Microbiology and Immunology. 171(1). 33–42. 4 indexed citations
9.
Armerding, Dieter, et al.. (1981). In-Vivo Modulation of Macrophage Functions by Herpes Simplex Virus Type 2 in Resistant and Sensitive Inbred Mouse Strains. Immunobiology. 160(2). 217–227. 18 indexed citations
10.
Scriba, M.. (1981). Persistence of Herpes simplex virus (HSV) infection in ganglia and peripheral tissues of guinea pigs. Medical Microbiology and Immunology. 169(2). 91–96. 37 indexed citations
11.
Scriba, M. & Franz Tatzber. (1981). Pathogenesis of Herpes simplex virus infections in guinea pigs. Infection and Immunity. 34(3). 655–661. 49 indexed citations
12.
Scriba, M., et al.. (1980). Use of [125I]deoxycytidine to detect herpes simplex virus-specific thymidine kinase in tissues of latently infected guinea pigs. Journal of Virology. 34(3). 644–649. 14 indexed citations
14.
Scriba, M.. (1975). Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection. Infection and Immunity. 12(1). 162–165. 69 indexed citations
15.
Scriba, M.. (1974). Stimulation of Peripheral Blood Lymphocytes by Herpes Simplex Virus in Vitro. Infection and Immunity. 10(3). 430–436. 17 indexed citations
16.
Dorner, Friedrich, M. Scriba, & Rudolf Weil. (1973). Interferon: Evidence for Its Glycoprotein Nature. Proceedings of the National Academy of Sciences. 70(7). 1981–1985. 50 indexed citations
17.
Henle, Werner, et al.. (1970). Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus. Science. 169(3941). 188–190. 493 indexed citations breakdown →
18.
Scriba, M. & W. Oehlert. (1969). Versuche zur übertragung der menschlichen Virushepatitis auf Marmosets. Medical Microbiology and Immunology. 155(1). 16–34. 1 indexed citations
19.
Scriba, M.. (1968). Experiments to eliminate mycoplasmas from tissue cultures by means of antibiotics.. 154(3). 3 indexed citations
20.
Scriba, M.. (1968). Versuche zur Beseitigung von Mycoplasmakontaminationen in Zellkulturen durch Antibiotica. Medical Microbiology and Immunology. 154(3). 267–276. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026